These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 1649751)

  • 21. Effect of mu and kappa opioid receptor agonists on rat plasma corticosterone levels.
    Hayes AG; Stewart BR
    Eur J Pharmacol; 1985 Oct; 116(1-2):75-9. PubMed ID: 2996912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Central kappa- and mu-opiate receptors mediate ACTH-release in rats.
    Pfeiffer A; Herz A; Loriaux DL; Pfeiffer DG
    Endocrinology; 1985 Jun; 116(6):2688-90. PubMed ID: 2986960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Functional effects of systemically administered agonists and antagonists of mu, delta, and kappa opioid receptor subtypes on body temperature in mice.
    Baker AK; Meert TF
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1253-64. PubMed ID: 12183687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. beta-Funaltrexamine antagonizes the analgesic effects of mu and kappa agonists in the formalin test.
    Abbott FV
    Pharmacol Biochem Behav; 1990 Dec; 37(4):713-6. PubMed ID: 1965514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
    Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
    J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antidiarrheal properties of supraspinal mu and delta and peripheral mu, delta and kappa opioid receptors: inhibition of diarrhea without constipation.
    Shook JE; Lemcke PK; Gehrig CA; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1989 Apr; 249(1):83-90. PubMed ID: 2540324
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression by nor-binaltorphimine of kappa opioid-mediated diuresis in rats.
    Takemori AE; Schwartz MM; Portoghese PS
    J Pharmacol Exp Ther; 1988 Dec; 247(3):971-4. PubMed ID: 2849679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chronic systemic administration of amphetamine increases food intake to morphine, but not to U50-488H, microinjected into the ventral tegmental area in rats.
    Nencini P; Stewart J
    Brain Res; 1990 Sep; 527(2):254-8. PubMed ID: 2174718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diurnal variation in prolactin, adrenocorticotropin and corticosterone release induced by opiate agonists in intact and adrenalectomized rats.
    Kiem DT; Kanyicska B; Stark E; Fekete MI
    Neuroendocrinology; 1987 Dec; 46(6):475-80. PubMed ID: 2892145
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dexamethasone selective inhibition of acute opioid physical dependence in isolated tissues.
    Capasso A; Di Giannuario A; Loizzo A; Pieretti S; Sagratella S; Sorrentino L
    J Pharmacol Exp Ther; 1996 Feb; 276(2):743-51. PubMed ID: 8632345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective tolerance at mu and kappa opioid receptors modulating norepinephrine release in guinea pig cortex.
    Werling LL; McMahon PN; Cox BM
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1103-6. PubMed ID: 2849659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pituitary-adrenocortical response to acute and chronic administration of U-50,488H in the rat.
    Milanés MV; Gonzalvez ML; Fuente T; Vargas ML
    Neuropeptides; 1991 Oct; 20(2):95-102. PubMed ID: 1665898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of mu and kappa opioid receptor agonists on cAMP level in hippocampus of kainic acid-treated rats.
    Dziedzicka-Wasylewska M; Przewłocki R
    Pol J Pharmacol; 1995; 47(2):121-6. PubMed ID: 8688884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo and in vitro studies on the opioidergic control of the secretion of gonadotrophin-releasing hormone and luteinizing hormone in sexually immature and adult male rats.
    Leposavic G; Cover PO; Buckingham JC
    Neuroendocrinology; 1991 Jun; 53(6):579-88. PubMed ID: 1652110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early ontogeny of kappa-opioid receptor regulation of prolactin secretion in the rat.
    Bero LA; Lurie SN; Kuhn CM
    Brain Res; 1987 Dec; 465(1-2):189-96. PubMed ID: 2894234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kappa opioid partial agonist activity of the enkephalin-like pentapeptide BW942C based on urination and in vitro studies in humans and animals.
    Vaupel DB; Cone EJ; Johnson RE; Su TP
    J Pharmacol Exp Ther; 1990 Jan; 252(1):225-34. PubMed ID: 2153801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of U-50,488H and U-50,488H withdrawal on catecholaminergic neurons of the rat hypothalamus.
    Laorden ML; Milanés MV
    Life Sci; 2000 Jan; 66(9):803-15. PubMed ID: 10698355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stimulation of adrenocorticotropin secretion by insulin-induced hypoglycemia in the developing rat involves arginine vasopressin but not corticotropin-releasing factor.
    Muret L; Priou A; Oliver C; Grino M
    Endocrinology; 1992 May; 130(5):2725-32. PubMed ID: 1315256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Agonist and antagonist activity of kappa opioids in the squirrel monkey: I. Antinociception and urine output.
    Craft RM; Dykstra LA
    J Pharmacol Exp Ther; 1992 Jan; 260(1):327-33. PubMed ID: 1309876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-tolerance between mu- and kappa-opioid agonists in the guinea pig ileum myenteric plexus.
    Garaulet JV; Laorden ML; Milanés MV
    J Pharmacol Exp Ther; 1994 Jun; 269(3):993-9. PubMed ID: 8014886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.